Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Recombinant, Bivalent, Norovirus Vaccine Study
Condition:   Norovirus Interventions:   Biological: Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (100 µg);   Biological: Norovirus GI.4 / GII.4 Bivalent VLP Vaccine (300 µg);   Drug: Placebo Sponsors:   Icon Genetics GmbH;   University Hospital, Ghent Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2022 Category: Research Source Type: clinical trials

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers
Condition:   Norovirus Infections Intervention:   Biological: VXA-G1.1-NN Sponsor:   Vaxart Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials